BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36683084)

  • 1. Analysis of LAP
    Cai H; Liu Y; Dong X; Jiang F; Li H; Ouyang S; Yin W; He T; Zeng Q; Yang H
    Neurol Sci; 2023 May; 44(5):1739-1747. PubMed ID: 36683084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
    Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
    Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
    Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
    Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.
    Elkord E; Abd Al Samid M; Chaudhary B
    Oncotarget; 2015 Aug; 6(24):20026-36. PubMed ID: 26343373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4
    Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
    Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme oxygenase-1 restores impaired GARPCD4⁺CD25⁺ regulatory T cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated T lymphocytes.
    Liu Y; Zhao X; Zhong Y; Meng K; Yu K; Shi H; Wu B; Tony H; Zhu J; Zhu R; Peng Y; Mao Y; Cheng P; Mao X; Zeng Q
    Cell Physiol Biochem; 2015; 35(2):553-70. PubMed ID: 25612606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disorders.
    Brill L; Lavon I; Vaknin-Dembinsky A
    Mult Scler Relat Disord; 2019 May; 30():114-118. PubMed ID: 30771576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in FoxP3- and GARP/LAP-Expressing T Regulatory Cells in an HLA Class II Transgenic Murine Model of Necrotizing Soft Tissue Infections by Group A Streptococcus.
    Nookala S; Mukundan S; Fife A; Alagarsamy J; Kotb M
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30224551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GARP/Latent TGF-β1 complex on Treg cells modulates the induction of peripherally derived Treg cells during oral tolerance.
    Edwards JP; Hand TW; Morais da Fonseca D; Glass DD; Belkaid Y; Shevach EM
    Eur J Immunol; 2016 Jun; 46(6):1480-9. PubMed ID: 27062243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral Blood Th1/Th17 Immune Cell Shift is Associated with Disease Activity and Severity of AQP4 Antibody Sero-Positive Neuromyelitis Optica Spectrum Disorder.
    Cao F; Wang Y; Wei R; Li C; Cheng Y; Zhou Y; Jin T; Zhang H; Lin L; Xu B
    Neuropsychiatr Dis Treat; 2023; 19():2413-2421. PubMed ID: 37965529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder.
    Ma X; Qin C; Chen M; Yu HH; Chu YH; Chen TJ; Bosco DB; Wu LJ; Bu BT; Wang W; Tian DS
    J Neuroinflammation; 2021 Sep; 18(1):201. PubMed ID: 34526069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in circulating TCF1- and GARP-associated regulatory T cell subsets reflect the clinical status of patients with chronic HBV infection.
    Bahabayi A; Zeng X; Tuerhanbayi B; Zhang Y; Hasimu A; Guo S; Liu T; Zheng M; Alimu X; Liu C
    Med Microbiol Immunol; 2022 Dec; 211(5-6):237-247. PubMed ID: 35953613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Garp as a therapeutic target for modulation of T regulatory cell function.
    Shevach EM
    Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder.
    Hoshino Y; Noto D; Sano S; Tomizawa Y; Yokoyama K; Hattori N; Miyake S
    J Neuroinflammation; 2022 Jan; 19(1):6. PubMed ID: 34991631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction.
    Oida T; Weiner HL
    PLoS One; 2010 Nov; 5(11):e15523. PubMed ID: 21124798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
    Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
    J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
    Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte Subsets Are Associated with Disease Status in Neuromyelitis Optica Spectrum Disorders.
    Yang H; Liu W; Wu YF; Zhu DS; Shen XF; Guan YT
    Neuroimmunomodulation; 2022; 29(4):296-305. PubMed ID: 34903694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
    Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
    Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.